The former hedge fund manager, vilified by the public and politicians after increasing the price of a prescription drug, is facing eight counts of securities and wire fraud.
NYS Entity Status
NYS Filing Date
APRIL 07, 2014
NYS DOS ID#
NYS Entity Type
DOMESTIC BUSINESS CORPORATION
2014 - NUSCINTA PHARMA INC.
AROUND THE WEB
- Martin Shkreli, ‘Pharma Bro,’ Prepares for Trial: ‘I’m So Innocent’
By STEPHANIE CLIFFORD - Thursday Jun 22, 2017
- Food & Wine Magazine Will Leave New York for Alabama
By STEPHANIE STROM - Friday Jun 23, 2017
The move reflects a changing business in which traditional food magazines, and a Manhattan address, are less important.
- Doctors Call On Big Pharma To Advertise Retail Prices Of Prescription Drugs
By Ashlee Kieler - Friday Jun 16, 2017
Think of the last prescription you had filled: You probably know how much you had to pay the pharmacy, but do you have any idea of the full sticker price for that medication? With many drug prices soaring, the nation’s largest physicians organization has called on the pharmaceuticals industry to be more transparent about the sometimes huge price tags …
- Checkmate Pharma Clinches $27M for More Studies in Skin Cancer
By Frank Vinluan - Thursday Jun 15, 2017
Checkmate Pharmaceuticals believes its approach to cancer treatment can make a certain type of immunotherapy work better, and it now has $27 million in additional funding to help build that case. F-Prime Capital Partners, a new investor, led the Series B round of investment announced Thursday. Sofinnova Partners and venBio, who had invested in Cambridge, […]
- Soupman Inc. of 'Seinfeld' Fame Seeks Bankruptcy Protection
Tuesday Jun 13, 2017
Soupman Inc., of “Seinfeld” fame, filed for bankruptcy protection Tuesday, just weeks after a top company executive was charged with tax evasion.
- Mylan Offered Discounts To States If They Made It Harder For Patients To Get Alternatives
By Ashlee Kieler - Thursday Jun 22, 2017
Controversial pharma company Mylan offered several states participating in Medicaid purchasing pools discounts on the EpiPen if they could ensure competitors’ products weren’t readily available to patients, according to a new report that raises additional concerns that the drugmaker engaged in anti-competitive practices as it raised the price of the life-saving drug nearly 400% in just 10 years. StatNews reports…
- A Slump in Tech Stocks That Leaves Some Investors Mystified
By LANDON THOMAS Jr. - Monday Jun 12, 2017
Shares of Netflix, Apple and other giant technology companies that have powered a market rally have taken an uncharacteristic pause.
- Ask the NY Giants: Socks with Sandals?
Tuesday Sep 15, 2015
Professional athletes like members of the New York Giants are the inspiration for the latest (counterintuitive) high-fashion trend: wearing socks with sandals. Photo: Stu Woo/The Wall Street Journal